Anavex Life Sciences Eulerpool Nieuws

Anavex Life Sciences Aandeel Nieuws

Anavex Life Sciences wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Anavex Life Sciences nieuwsberichten verzamelen we hier.

• 11 november ·

  SeekingAlpha
  Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
• 6 november ·

  SeekingAlpha
  Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval Scenario
• 5 november ·

  SeekingAlpha
  Anavex: Understanding Their Latest Alzheimer's Data News With Caution
• 31 oktober ·

  Benzinga
  12 Health Care Stocks Moving In Thursday's Intraday Session
• 31 oktober ·

  TipRanks
  Anavex Life Sciences’ Promising Alzheimer’s Drug: Buy Rating Justified by Positive Clinical Outcomes and Strategic Advantages
• 31 oktober ·

  Yahoo
  Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
• 31 oktober ·

  TipRanks
  Anavex presents new data from blarcamesine study at CTAD conference
• 18 oktober ·

  TipRanks
  Buy Rating Affirmed for Anavex Life Sciences Amid Promising Clinical Developments and Market Prospects
• 17 oktober ·

  Yahoo
  Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
• 17 oktober ·

  Thefly.com
  Anavex announces preliminary biomarker results from Phase 2 study of ANAVEX 3-71